Insider · CIK 0001868997

Gillies Hunter

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001868997

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-13	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,000 sh	$2.14	+$12.8K	11,602
2024-06-13	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−6,000 sh	$24.50	−$147K	5,602
2024-06-13	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−6,000 sh	—	—	83,510
2024-05-17	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+4,000 sh	$2.14	+$8,560	9,602
2024-05-17	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−3,914 sh	$21.07	−$82.5K	5,688
2024-05-17	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−86 sh	$21.86	−$1,879.96	5,602
2024-05-17	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−4,000 sh	—	—	11,324
2024-04-17	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+4,000 sh	$1.74	+$6,960	7,251
2024-04-17	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−3,689 sh	$22.30	−$82.3K	3,562
2024-04-17	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−311 sh	$23.33	−$7,254.915	3,251
2024-04-17	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−503 sh	—	—	2,511
2024-04-17	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−3,497 sh	—	—	539
2024-03-28	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+9,000 sh	$2.14	+$19.3K	12,251
2024-03-28	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−9,000 sh	$29.50	−$266K	3,251
2024-03-28	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−9,000 sh	—	—	89,510
2024-03-18	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+4,000 sh	$1.74	+$6,960	7,251
2024-03-18	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+3,000 sh	$2.14	+$6,420	10,251
2024-03-18	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−6,387 sh	$25.81	−$165K	3,864
2024-03-18	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−613 sh	$26.40	−$16.2K	3,251
2024-03-18	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−4,000 sh	—	—	4,036
2024-03-18	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−3,000 sh	—	—	98,510
2024-03-07	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+8,975 sh	$2.14	+$19.2K	12,226
2024-03-07	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−8,975 sh	$24.50	−$220K	3,251
2024-03-07	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−945 sh	—	—	15,324
2024-03-07	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−8,030 sh	—	—	101,510
2024-02-23	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+511 sh	$1.74	+$889.14	3,762
2024-02-23	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−511 sh	$19.50	−$9,964.5	3,251
2024-02-23	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−511 sh	—	—	3,014
2024-02-20	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+3,489 sh	$1.74	+$6,070.86	6,740
2024-02-20	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,591 sh	$20.11	−$52.1K	4,149
2024-02-20	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−898 sh	$20.58	−$18.5K	3,251
2024-02-20	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,502 sh	—	—	3,525
2024-02-20	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−987 sh	—	—	8,036
2024-01-22	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+66.6K sh	—	—	66,586
2024-01-17	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+4,000 sh	$1.74	+$6,960	7,251
2024-01-17	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−4,000 sh	$19.50	−$78K	3,251
2024-01-17	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−4,000 sh	—	—	6,027
2023-12-27	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+125 sh	$2.14	+$267.5	3,376
2023-12-27	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−125 sh	$24.50	−$3,062.5	3,251
2023-12-27	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−25 sh	—	—	16,269
2023-12-27	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−100 sh	—	—	109,540
2023-12-20	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−4,000 sh	$19.50	−$78K	3,251
2023-12-20	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,924 sh	—	—	9,023
2023-12-20	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−1,076 sh	—	—	10,027
2023-12-14	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+9,897 sh	$1.74	+$17.2K	13,148
2023-12-14	JBIOJade Biosciences, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−9,897 sh	$19.50	−$193K	3,251
2023-12-14	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,700 sh	—	—	12,744
2023-12-14	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−7,197 sh	—	—	10,306
2023-12-13	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+4,000 sh	$1.74	+$6,960	7,251
2023-12-13	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,103 sh	$1.74	+$3,659.22	5,354

Recent filings

Accepted (ET)
Jun 144
Gillies Hunter0001415889-24-016993
SEC(opens sec.gov)
May 174
Gillies Hunter0001415889-24-013630
SEC(opens sec.gov)
Apr 194
Gillies Hunter0001415889-24-011251
SEC(opens sec.gov)
Apr 14
Gillies Hunter0001415889-24-009596
SEC(opens sec.gov)
Mar 204
Gillies Hunter0001415889-24-008771
SEC(opens sec.gov)

Companies

Jade Biosciences, Inc.CHIEF MEDICAL OFFICERJBIO

Address

C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18

BOSTON, MA, 02116